COVID-19 A&E diagnosis codes

Download CSV Download definition

Codelist metadata

Coding system

SNOMED CT

Coding system release

35.2.0

Organisation

OpenSAFELY

Codelist ID

opensafely/covid-19-ae-diagnosis-codes

Version ID

1df1c0b2

Versions

  • 1df1c0b2 Updated: 2023-11-26 18:08:36

About

Description

SNOMED diagnosis codes for identifying people presenting to A&E with COVID-19. These codes are intended for use with NHS Emergency Care Data Set (ECDS) data only. Note that 1240751000000100 is deprecated as of 31 March 2022. The other three codes (1325171000000109, 1325181000000106, 1325161000000102) were introduced on 1 July 2021.

Methodology

Codes are based on COVID-19 related SNOMED codes in the NHS Emergency Care Data Set (ECDS) Enhanced Technical Output Specification (ETOS) version 4.0. The diagnosis field in ECDS should only contain the codes listed in this document. Note that while ETOS version 4.0 will be implemented on 1 July 2023, the COVID-19 related codes are the same in the previous version (v3.1.1).

References

Signed off by

  • Andrea Schaffer, (Feb. 8, 2023)
  • Chris Wood, (Feb. 7, 2023)
  • Will Hulme, (Feb. 8, 2023)

Codelists are developed by a broad community of users for individual study purposes, which may or may not meet the needs of other studies. They should not be thought of as universal definitions of a particular condition.

We don't offer any guarantees about what they do or don't identify. Users should carefully check that any codelist meets their needs, and seek clinical input where appropriate.

code term
1240751000000100 Coronavirus disease 19 caused by severe acute respiratory syndrome coronavirus 2
1325161000000102 Post-COVID-19 syndrome
1325171000000109 Acute disease caused by severe acute respiratory syndrome coronavirus 2 infection
1325181000000106 Ongoing symptomatic disease caused by severe acute respiratory syndrome coronavirus 2

Codes not in the full codelist are in faint grey.

This page shows the search terms that were used to build the codelist. Concepts that match the search terms, but which were excluded, are in faint grey.

1240751000000100

Included 0 out of 0 matching concepts.

Show matching concepts

1325161000000102

Included 0 out of 0 matching concepts.

Show matching concepts

1325171000000109

Included 0 out of 0 matching concepts.

Show matching concepts

1325181000000106

Included 0 out of 0 matching concepts.

Show matching concepts

covid-19

Included 4 out of 176 matching concepts.

Show matching concepts
  • Acute bronchitis caused by severe acute respiratory syndrome coronavirus 2 (138389411000119105)
  • Acute disease caused by severe acute respiratory syndrome coronavirus 2 (1119302008)
  • Acute disease caused by severe acute respiratory syndrome coronavirus 2 infection (1325171000000109)
  • Acute hypoxemic respiratory failure due to disease caused by severe acute respiratory syndrome coronavirus 2 (870590002)
  • Acute kidney injury due to disease caused by severe acute respiratory syndrome coronavirus 2 (870589006)
  • Acute respiratory distress syndrome due to disease caused by severe acute respiratory syndrome coronavirus 2 (674814021000119106)
  • Administration of fifth dose of severe acute respiratory syndrome coronavirus 2 vaccine (1363831000000108)
  • Administration of first dose of severe acute respiratory syndrome coronavirus 2 vaccine (1324681000000101)
  • Administration of first dose of vaccine product containing only severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid (1144997007)
  • Administration of fourth dose of severe acute respiratory syndrome coronavirus 2 vaccine (1363791000000101)
  • Administration of second dose of severe acute respiratory syndrome coronavirus 2 vaccine (1324691000000104)
  • Administration of second dose of vaccine product containing only inactivated whole severe acute respiratory syndrome coronavirus 2 antigen (1157197009)
  • Administration of second dose of vaccine product containing only severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid (1144998002)
  • Administration of second dose of vaccine product containing only severe acute respiratory syndrome coronavirus 2 recombinant spike protein antigen (1162646009)
  • Administration of second dose of vaccine product containing only severe acute respiratory syndrome coronavirus 2 virus-like particle antigen (1179497009)
  • Administration of second dose vaccine product containing only recombinant non-replicating viral vector encoding severe acute respiratory syndrome coronavirus 2 spike protein (1157108008)
  • Administration of third dose of severe acute respiratory syndrome coronavirus 2 vaccine (1363861000000103)
  • Administration of vaccine product against severe acute respiratory syndrome coronavirus 2 (1156257007)
  • Administration of vaccine product containing only inactivated whole severe acute respiratory syndrome coronavirus 2 antigen (1157196000)
  • Administration of vaccine product containing only recombinant non-replicating viral vector encoding severe acute respiratory syndrome coronavirus 2 spike protein (1157107003)
  • Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 antigen (840534001)
  • Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 deoxyribonucleic acid plasmid encoding spike protein (1193583000)
  • Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid (1119350007)
  • Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 recombinant spike protein antigen (1162645008)
  • Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 virus-like particle antigen (1179496000)
  • Adverse reaction to component of vaccine product against severe acute respiratory syndrome coronavirus 2 (1156256003)
  • Adverse reaction to component of vaccine product containing Severe acute respiratory syndrome coronavirus 2 antigen or Severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid (1142180003)
  • Adverse reaction to component of vaccine product containing only inactivated whole severe acute respiratory syndrome coronavirus 2 antigen (1157195001)
  • Adverse reaction to component of vaccine product containing only recombinant non-replicating viral vector encoding severe acute respiratory syndrome coronavirus 2 spike protein (1157106007)
  • Adverse reaction to component of vaccine product containing only severe acute respiratory syndrome coronavirus 2 antigen (1142182006)
  • Adverse reaction to component of vaccine product containing only severe acute respiratory syndrome coronavirus 2 deoxyribonucleic acid plasmid encoding spike protein (1193581003)
  • Adverse reaction to component of vaccine product containing only severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid (1142181004)
  • Adverse reaction to component of vaccine product containing only severe acute respiratory syndrome coronavirus 2 recombinant spike protein antigen (1162644007)
  • Adverse reaction to component of vaccine product containing only severe acute respiratory syndrome coronavirus 2 virus-like particle antigen (1179495001)
  • Application for medical exemption from severe acute respiratory syndrome coronavirus 2 vaccination approved (1365751000000105)
  • Application for medical exemption from severe acute respiratory syndrome coronavirus 2 vaccination rejected (1365761000000108)
  • Assessment using COVID-19 Yorkshire Rehabilitation Screening tool (1325081000000107)
  • Assessment using NHS Digital COVID-19 Clinical Risk Assessment Tool (1325951000000102)
  • Assessment using Post-COVID-19 Functional Status Scale patient self-report (1325101000000101)
  • Assessment using Post-COVID-19 Functional Status Scale structured interview (1325141000000103)
  • Assessment using coronavirus disease 19 severity scale (1300681000000102)
  • Asymptomatic severe acute respiratory syndrome coronavirus 2 infection (189486241000119100)
  • At increased risk of exposure to severe acute respiratory syndrome coronavirus 2 (870577009)
  • COVID-19 Yorkshire Rehabilitation Screening tool (1325071000000105)
  • COVID-19 testing site (1163582002)
  • Cardiomyopathy due to disease caused by severe acute respiratory syndrome coronavirus 2 (119731000146105)
  • Chronic post-COVID-19 syndrome (1119304009)
  • Close exposure to severe acute respiratory syndrome coronavirus 2 infection (1240441000000108)
  • Conjunctivitis due to disease caused by severe acute respiratory syndrome coronavirus 2 (119741000146102)
  • Coronavirus disease 19 caused by severe acute respiratory syndrome coronavirus 2 (1240751000000100)
  • Coronavirus disease 19 caused by severe acute respiratory syndrome coronavirus 2 confirmed by laboratory test (1300721000000109)
  • Coronavirus disease 19 caused by severe acute respiratory syndrome coronavirus 2 confirmed using clinical diagnostic criteria (1300731000000106)
  • Coronavirus disease 19 caused by severe acute respiratory syndrome coronavirus 2 excluded (1321101000000103)
  • Coronavirus disease 19 caused by severe acute respiratory syndrome coronavirus 2 excluded by laboratory test (1321111000000101)
  • Coronavirus disease 19 caused by severe acute respiratory syndrome coronavirus 2 excluded using clinical diagnostic criteria (1321121000000107)
  • Coronavirus disease 19 caused by severe acute respiratory syndrome coronavirus 2 health issues simple reference set (1321201000000107)
  • Coronavirus disease 19 caused by severe acute respiratory syndrome coronavirus 2 presenting complaints simple reference set (1321211000000109)
  • Coronavirus disease 19 caused by severe acute respiratory syndrome coronavirus 2 procedures simple reference set (1321191000000105)
  • Coronavirus disease 19 caused by severe acute respiratory syndrome coronavirus 2 record extraction simple reference set (1321181000000108)
  • Coronavirus disease 19 severity scale (1300671000000104)
  • Coronavirus disease 19 severity score (1300631000000101)
  • Deoxyribonucleic acid of severe acute respiratory syndrome coronavirus 2 (1179416004)
  • Deoxyribonucleic acid plasmid encoding severe acute respiratory syndrome coronavirus 2 spike protein (1187591006)
  • Detection of ribonucleic acid of severe acute respiratory syndrome coronavirus 2 (871555000)
  • Detection of ribonucleic acid of severe acute respiratory syndrome coronavirus 2 in bronchoalveolar lavage fluid (871559006)
  • Detection of ribonucleic acid of severe acute respiratory syndrome coronavirus 2 in nasopharyngeal swab (871556004)
  • Detection of ribonucleic acid of severe acute respiratory syndrome coronavirus 2 in oropharyngeal swab (871557008)
  • Detection of ribonucleic acid of severe acute respiratory syndrome coronavirus 2 in sputum (871558003)
  • Detection of ribonucleic acid of severe acute respiratory syndrome coronavirus 2 using polymerase chain reaction (871560001)
  • Detection of severe acute respiratory syndrome coronavirus 2 (871562009)
  • Detection of severe acute respiratory syndrome coronavirus 2 antigen (871553007)
  • Disease caused by severe acute respiratory syndrome coronavirus 2 (840539006)
  • Disease caused by severe acute respiratory syndrome coronavirus 2 absent (688232241000119100)
  • Disease caused by severe acute respiratory syndrome coronavirus 2 following administration of vaccine product against severe acute respiratory syndrome coronavirus 2 (1217296006)
  • Dyspnea caused by severe acute respiratory syndrome coronavirus 2 (119981000146107)
  • Elasomeran (1172706007)
  • Encephalopathy due to disease caused by severe acute respiratory syndrome coronavirus 2 (1240561000000108)
  • Exposure to confirmed case of severe acute respiratory syndrome coronavirus 2 infection (1321821000000104)
  • Exposure to severe acute respiratory syndrome coronavirus 2 (840546002)
  • Exposure to suspected case of severe acute respiratory syndrome coronavirus 2 infection (1321831000000102)
  • Fever caused by severe acute respiratory syndrome coronavirus 2 (119751000146104)
  • Gastroenteritis caused by severe acute respiratory syndrome coronavirus 2 (1240571000000101)
  • High risk category for developing complication from coronavirus disease 19 caused by severe acute respiratory syndrome coronavirus 2 infection (1300561000000107)
  • History of disease caused by severe acute respiratory syndrome coronavirus 2 (292508471000119105)
  • Hypersensitivity to vaccine product containing only severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid (1145003007)
  • Inactivated whole severe acute respiratory syndrome coronavirus 2 antigen vaccine contraindicated (1157198004)
  • Inactivated whole severe acute respiratory syndrome coronavirus 2 antigen vaccine declined (1157200005)
  • Infection of lower respiratory tract caused by severe acute respiratory syndrome coronavirus 2 (880529761000119102)
  • Infection of upper respiratory tract caused by severe acute respiratory syndrome coronavirus 2 (1240541000000107)
  • Low risk category for developing complication from coronavirus disease 19 caused by severe acute respiratory syndrome coronavirus 2 infection (1300591000000101)
  • Lymphocytopenia due to severe acute respiratory syndrome coronavirus 2 (866151004)
  • Measurement of severe acute respiratory syndrome coronavirus 2 antibody (1240461000000109)
  • Measurement of severe acute respiratory syndrome coronavirus 2 antigen (1240471000000102)
  • Messenger ribonucleic acid of severe acute respiratory syndrome coronavirus 2 (1119343008)
  • Messenger ribonucleic acid of severe acute respiratory syndrome coronavirus 2 encoding spike protein (1155866009)
  • Moderate risk category for developing complication from coronavirus disease 19 caused by severe acute respiratory syndrome coronavirus 2 infection (1300571000000100)
  • Multisystem inflammatory syndrome in children (895448002)
  • Myocarditis due to disease caused by severe acute respiratory syndrome coronavirus 2 (1240531000000103)
  • NHS Digital COVID-19 Clinical Risk Assessment Tool (1325961000000104)
  • NHS Digital COVID-19 Clinical Risk Assessment Tool combined risk of catching and dying from COVID-19 absolute risk score (1325971000000106)
  • NHS Digital COVID-19 Clinical Risk Assessment Tool combined risk of catching and dying from COVID-19 relative risk score (1325981000000108)
  • NHS Digital COVID-19 Clinical Risk Assessment Tool combined risk of catching and hospitalisation from COVID-19 absolute risk score (1326001000000109)
  • NHS Digital COVID-19 Clinical Risk Assessment Tool combined risk of catching and hospitalisation from COVID-19 relative risk score (1325991000000105)
  • Occupational exposure to severe acute respiratory syndrome coronavirus 2 (897036007)
  • Ongoing symptomatic disease caused by severe acute respiratory syndrome coronavirus 2 (1325181000000106)
  • Otitis media due to disease caused by severe acute respiratory syndrome coronavirus 2 (1240521000000100)
  • Pneumonia caused by severe acute respiratory syndrome coronavirus 2 (882784691000119100)
  • Post-COVID-19 Functional Status Scale patient self-report (1325091000000109)
  • Post-COVID-19 Functional Status Scale patient self-report final scale grade (1325121000000105)
  • Post-COVID-19 Functional Status Scale structured interview (1325151000000100)
  • Post-COVID-19 Functional Status Scale structured interview final scale grade (1325131000000107)
  • Post-COVID-19 syndrome (1325161000000102)
  • Post-COVID-19 syndrome resolved (1326351000000108)
  • Post-COVID-19 syndrome service (1325831000000100)
  • Post-acute COVID-19 (1119303003)
  • Provision of advice, assessment or treatment delayed due to coronavirus disease 19 caused by severe acute respiratory syndrome coronavirus 2 pandemic (1321851000000109)
  • Provision of advice, assessment or treatment limited due to coronavirus disease 19 caused by severe acute respiratory syndrome coronavirus 2 pandemic (1321171000000106)
  • Referral to post-COVID assessment clinic (1325031000000108)
  • Rhabdomyolysis due to disease caused by severe acute respiratory syndrome coronavirus 2 (870591003)
  • Ribonucleic acid of severe acute respiratory syndrome coronavirus 2 (1240411000000107)
  • Second dose of inactivated whole severe acute respiratory syndrome coronavirus 2 antigen vaccine contraindicated (1157199007)
  • Second dose of inactivated whole severe acute respiratory syndrome coronavirus 2 antigen vaccine declined (1157201009)
  • Second dose of severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid vaccine contraindicated (1145035007)
  • Second dose of severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid vaccine declined (1145034006)
  • Second dose of severe acute respiratory syndrome coronavirus 2 non-replicating viral vector vaccine contraindicated (1157113007)
  • Second dose of severe acute respiratory syndrome coronavirus 2 non-replicating viral vector vaccine declined (1157120000)
  • Second dose of severe acute respiratory syndrome coronavirus 2 recombinant spike protein antigen vaccine contraindicated (1162648005)
  • Second dose of severe acute respiratory syndrome coronavirus 2 recombinant spike protein antigen vaccine declined (1162650002)
  • Second dose of severe acute respiratory syndrome coronavirus 2 virus-like particle antigen vaccine contraindicated (1179499007)
  • Second dose of severe acute respiratory syndrome coronavirus 2 virus-like particle antigen vaccine declined (1179501004)
  • Sepsis due to disease caused by severe acute respiratory syndrome coronavirus 2 (870588003)
  • Severe acute respiratory syndrome coronavirus 2 antibody test negative (897035006)
  • Severe acute respiratory syndrome coronavirus 2 antibody test positive (897034005)
  • Severe acute respiratory syndrome coronavirus 2 antigen or Severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid vaccination not indicated (1145028004)
  • Severe acute respiratory syndrome coronavirus 2 antigen or Severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid vaccine contraindicated (1145026000)
  • Severe acute respiratory syndrome coronavirus 2 antigen or Severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid vaccine declined (1145031003)
  • Severe acute respiratory syndrome coronavirus 2 antigen vaccination not indicated (1145030002)
  • Severe acute respiratory syndrome coronavirus 2 antigen vaccine contraindicated (1145023008)
  • Severe acute respiratory syndrome coronavirus 2 antigen vaccine declined (1145033000)
  • Severe acute respiratory syndrome coronavirus 2 deoxyribonucleic acid plasmid encoding spike protein vaccine contraindicated (1193584006)
  • Severe acute respiratory syndrome coronavirus 2 deoxyribonucleic acid plasmid encoding spike protein vaccine declined (1193582005)
  • Severe acute respiratory syndrome coronavirus 2 detected (1240581000000104)
  • Severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid vaccination not indicated (1145029007)
  • Severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid vaccine contraindicated (1145022003)
  • Severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid vaccine declined (1145032005)
  • Severe acute respiratory syndrome coronavirus 2 non-replicating viral vector vaccine contraindicated (1157110005)
  • Severe acute respiratory syndrome coronavirus 2 non-replicating viral vector vaccine declined (1157118003)
  • Severe acute respiratory syndrome coronavirus 2 not detected (1240591000000102)
  • Severe acute respiratory syndrome coronavirus 2 recombinant spike protein antigen vaccine contraindicated (1162647000)
  • Severe acute respiratory syndrome coronavirus 2 recombinant spike protein antigen vaccine declined (1162649002)
  • Severe acute respiratory syndrome coronavirus 2 ribonucleic acid detected (1324601000000106)
  • Severe acute respiratory syndrome coronavirus 2 ribonucleic acid not detected (1324581000000102)
  • Severe acute respiratory syndrome coronavirus 2 vaccination declined (1156270003)
  • Severe acute respiratory syndrome coronavirus 2 vaccination fifth dose declined (1363851000000101)
  • Severe acute respiratory syndrome coronavirus 2 vaccination first dose declined (1324741000000101)
  • Severe acute respiratory syndrome coronavirus 2 vaccination fourth dose declined (1363811000000100)
  • Severe acute respiratory syndrome coronavirus 2 vaccination not indicated (1156267002)
  • Severe acute respiratory syndrome coronavirus 2 vaccination second dose declined (1324751000000103)
  • Severe acute respiratory syndrome coronavirus 2 vaccination third dose declined (1363781000000103)
  • Severe acute respiratory syndrome coronavirus 2 vaccine contraindicated (1156265005)
  • Severe acute respiratory syndrome coronavirus 2 virus-like particle antigen vaccine contraindicated (1179498004)
  • Severe acute respiratory syndrome coronavirus 2 virus-like particle antigen vaccine declined (1179500003)
  • Signposting to coronavirus disease 19 Home Management Service (1321231000000101)
  • Suspected coronavirus disease 19 caused by severe acute respiratory syndrome coronavirus 2 (1240761000000102)
  • Suspected disease caused by Severe acute respiratory coronavirus 2 (840544004)
  • Thrombocytopenia due to severe acute respiratory syndrome coronavirus 2 (866152006)
  • Tozinameran (1157170002)
  • Vaccine product against severe acute respiratory syndrome coronavirus 2 (28531000087107)
  • Vaccine product containing only inactivated whole severe acute respiratory syndrome coronavirus 2 antigen (1157024006)
  • Vaccine product containing only recombinant non-replicating viral vector encoding severe acute respiratory syndrome coronavirus 2 spike protein (29061000087103)
  • Vaccine product containing only severe acute respiratory syndrome coronavirus 2 antigen (1119305005)
  • Vaccine product containing only severe acute respiratory syndrome coronavirus 2 deoxyribonucleic acid plasmid encoding spike protein (1187593009)
  • Vaccine product containing only severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid (1119349007)
  • Vaccine product containing only severe acute respiratory syndrome coronavirus 2 recombinant spike protein antigen (1162643001)
  • Vaccine product containing only severe acute respiratory syndrome coronavirus 2 virus-like particle antigen (30141000087107)
  • Viremia caused by severe acute respiratory syndrome coronavirus 2 (1017214008)